Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy. (gut.bmj.com)

Authors: Iglesias Coma M … Calon A Journal: Gut Published: 2026-04-14 DOI: https://doi.org/10.1136/gutjnl-2025-336804